RxDoctor Payments Data

Michael Ehrenreich, MD

Dermatology · Millburn, NJNPI 1124249644

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $548, 3.0 times the $182 reported in 2019. That places this record below the midpoint for dermatology clinicians in NJ, where the typical reported total is $1,986.

$1,390in general payments, 2019–2025

Across 77 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$214
  • Merz North America, Inc.$192
  • Incyte Corporation$162
  • Johnson & Johnson$104
  • Sun Pharmaceutical Industries Inc.$94
  • Sanofi$90
  • plus $534 from 18 others

What the payments were for

  • Food & beverage$1,30494%
  • Education$866%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,390 in reported general payments places this provider in the 40th percentile of 394 dermatology providers in New Jersey.

See all dermatology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$61,505
Medicare patients
128
Services billed
598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$43,170
Clobetasol Propionate32$1,357
Desonide15$667
Triamcinolone Acetonide31$615

Paid to pharmacies, not to this prescriber.

Other dermatology in Millburn

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →